Accession Number: | 0001209191-22-029459 |
Date: | 2022-05-13 |
Issuer: | BIONANO GENOMICS, INC. (BNGO) |
Original Submission Date: |
STEWART CHRISTOPHER P.
C/O BIONANO GENOMICS, INC.
9540 TOWNE CENTRE DRIVE, SUITE 100
SAN DIEGO, CA 92121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-05-13 | M | 60,000 | a | $0.56 | 121,579 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 0.56 | 2022-05-13 | deemed execution date | M | 60,000 (d) | 2030-09-01 | common stock 60,000 | $0.56 | 117,500 | direct |
ID | footnote |
---|---|
f1 | includes 3,139 shares acquired under the issuer's 2018 employee stock purchase plan (the "espp") on june 10, 2021 and 2,940 shares acquired under the espp on december 10, 2021. |
f2 | the shares vest in full on december 31, 2020, subject to reporting person's continuous service through december 31, 2020, subject to acceleration of vesting provided in the employment agreement, dated as of september 1, 2020, by and between the issuer and the reporting person. |